MedPath

Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Registration Number
NCT00005865
Lead Sponsor
GlaxoSmithKline
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. It is not yet known whether giving vinorelbine by mouth or infusion is more effective in treating non- small cell lung cancer.

PURPOSE: Randomized phase II trial to compare the effectiveness of vinorelbine given by mouth or as an infusion in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Detailed Description

OBJECTIVES: I. Compare the safety and efficacy of oral versus intravenous vinorelbine in patients with stage IIIB or IV non-small cell lung cancer. II. Compare the quality of life of patients treated with these regimens. III. Compare the pharmacokinetics of these treatment regimens in this patient population.

OUTLINE: This is a randomized, multicenter study. Patients are randomized to one of two treatment arms. Arm I: Patients receive oral vinorelbine weekly. Arm II: Patients receive vinorelbine IV over 10 minutes weekly. Treatment continues in the absence of disease progression or unacceptable toxicity. Quality of life is assessed several times during treatment and 4 weeks after treatment. Patients are followed every 3 months for 1 year.

PROJECTED ACCRUAL: A maximum of 195 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (50)

NorthBay Healthcare System

πŸ‡ΊπŸ‡Έ

Fairfield, California, United States

University of Chicago Cancer Research Center

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Ireland Cancer Center

πŸ‡ΊπŸ‡Έ

Cleveland, Ohio, United States

University of Pittsburgh Cancer Institute

πŸ‡ΊπŸ‡Έ

Pittsburgh, Pennsylvania, United States

St. Luke's Hospital

πŸ‡ΊπŸ‡Έ

Duluth, Minnesota, United States

Medical Oncology, LLC

πŸ‡ΊπŸ‡Έ

Baton Rouge, Louisiana, United States

Norris Cotton Cancer Center

πŸ‡ΊπŸ‡Έ

Lebanon, New Hampshire, United States

Sparrow Regional Cancer Center

πŸ‡ΊπŸ‡Έ

Lansing, Michigan, United States

McGill University

πŸ‡¨πŸ‡¦

Montreal, Quebec, Canada

Veterans Affairs Medical Center - San Juan

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Trinitas Hospital - Jersey Street Campus

πŸ‡ΊπŸ‡Έ

Elizabeth, New Jersey, United States

Arizona Clinical Research Center

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Highlands Oncology Group, P.A.

πŸ‡ΊπŸ‡Έ

Fayetteville, Arkansas, United States

Berkshire Physicians and Surgeons, P.C.

πŸ‡ΊπŸ‡Έ

Pittsfield, Massachusetts, United States

Providence Hospital Cancer Center

πŸ‡ΊπŸ‡Έ

Southfield, Michigan, United States

Cancer Resource Center - Lincoln

πŸ‡ΊπŸ‡Έ

Lincoln, Nebraska, United States

Northern NJ Cancer Associates

πŸ‡ΊπŸ‡Έ

Hackensack, New Jersey, United States

Office of Luis Alberto Meza

πŸ‡ΊπŸ‡Έ

Lafayette, Louisiana, United States

Lakeland Medical Center - St. Joseph

πŸ‡ΊπŸ‡Έ

Saint Joseph, Michigan, United States

Wilshire Oncology Medical Center

πŸ‡ΊπŸ‡Έ

Pomona, California, United States

South Bend Clinic and SurgiCenter

πŸ‡ΊπŸ‡Έ

South Bend, Indiana, United States

Mercy Oncology-Hematology Limited

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

Veterans Affairs Medical Center - Buffalo

πŸ‡ΊπŸ‡Έ

Buffalo, New York, United States

Lakeridge Health Oshawa

πŸ‡¨πŸ‡¦

Oshawa, Ontario, Canada

Office of Janak K. Choksi

πŸ‡ΊπŸ‡Έ

Burlington, North Carolina, United States

Memphis Cancer Center

πŸ‡ΊπŸ‡Έ

Memphis, Tennessee, United States

Cancer Centers of the Carolinas

πŸ‡ΊπŸ‡Έ

Greenville, South Carolina, United States

Simmons Cancer Center - Dallas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

Hematology Oncology Consultants Inc

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

Medical Group of Texas

πŸ‡ΊπŸ‡Έ

Dallas, Texas, United States

West Clinic, P.C.

πŸ‡ΊπŸ‡Έ

Memphis, Tennessee, United States

Office of Hal Gerstein

πŸ‡ΊπŸ‡Έ

Great Neck, New York, United States

NYU School of Medicine's Kaplan Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Raleigh Hematology/Oncology Associates - Wake Practice

πŸ‡ΊπŸ‡Έ

Raleigh, North Carolina, United States

HillCrest Hospital

πŸ‡ΊπŸ‡Έ

Mayfield Heights, Ohio, United States

Veterans Affairs Medical Center - Tucson

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Genesis Cancer Center

πŸ‡ΊπŸ‡Έ

Hot Springs, Arkansas, United States

Comprehensive Cancer Care Specialists of Boca Raton

πŸ‡ΊπŸ‡Έ

Boca Raton, Florida, United States

West Florida Cancer Institute - Pensacola

πŸ‡ΊπŸ‡Έ

Pensacola, Florida, United States

Cancer Care Consultants of Northern California

πŸ‡ΊπŸ‡Έ

Redding, California, United States

Saint Vincents Comprehensive Breast Center

πŸ‡ΊπŸ‡Έ

New York, New York, United States

Washington University Barnard Cancer Center

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

Veterans Affairs Medical Center - Northport

πŸ‡ΊπŸ‡Έ

Northport, New York, United States

Joe Arrington Cancer Center

πŸ‡ΊπŸ‡Έ

Lubbock, Texas, United States

MultiCare Hematolgy/Oncology Clinic

πŸ‡ΊπŸ‡Έ

Tacoma, Washington, United States

University of Puerto Rico School of Medicine Medical Sciences Campus

πŸ‡΅πŸ‡·

San Juan, Puerto Rico

Barbara Ann Karmanos Cancer Institute

πŸ‡ΊπŸ‡Έ

Detroit, Michigan, United States

Comprehensive Cancer Center at Wake Forest University

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

Lovelace Health Systems

πŸ‡ΊπŸ‡Έ

Albuquerque, New Mexico, United States

University of Rochester Cancer Center

πŸ‡ΊπŸ‡Έ

Rochester, New York, United States

Β© Copyright 2025. All Rights Reserved by MedPath